Ben Gil Price, Director at AVI BIOPHARMA INC (AVII), bought 40,000 shares at $1.36 ($54K) on 2010-05-13, disclosed to the SEC on 2010-05-13.
Open-market purchase of $54k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SRPT | BUY | 2013-08-20 | $16K | — | Filing → |
| AVII | BUY | 2012-03-15 | $39K | — | Filing → |
| AVII | BUY | 2011-04-06 | $30K | — | Filing → |